- Investing Ideas
- /
- U.S. Top High Growth Tech & AI Stocks - Spotless Financials
U.S. Top High Growth Tech & AI Stocks - Spotless Financials
Results
66
Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.
66 companies
Circle Internet Group
Market Cap: US$35.1b
Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.
CRCL
US$139.23
7D
-9.0%
1Y
n/a
Mereo BioPharma Group
Market Cap: US$272.1m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
MREO
US$1.71
7D
11.8%
1Y
-60.5%
Palantir Technologies
Market Cap: US$429.4b
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
PLTR
US$181.02
7D
-3.2%
1Y
464.3%
Vanda Pharmaceuticals
Market Cap: US$257.6m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.43
7D
5.5%
1Y
-14.3%
Aldeyra Therapeutics
Market Cap: US$317.4m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.
ALDX
US$5.30
7D
2.5%
1Y
1.0%
ACADIA Pharmaceuticals
Market Cap: US$4.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$24.53
7D
-0.3%
1Y
59.3%
ADMA Biologics
Market Cap: US$4.1b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$16.97
7D
1.3%
1Y
-3.5%
OS Therapies
Market Cap: US$62.9m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$2.15
7D
22.9%
1Y
-39.3%
RenovoRx
Market Cap: US$45.3m
A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$1.24
7D
3.3%
1Y
11.7%
Workday
Market Cap: US$59.2b
Provides enterprise cloud applications in the United States and internationally.
WDAY
US$221.92
7D
-0.07%
1Y
-4.2%
Gorilla Technology Group
Market Cap: US$504.6m
Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.
GRRR
US$16.80
7D
6.8%
1Y
551.2%
Atlassian
Market Cap: US$43.0b
Through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide.
TEAM
US$164.39
7D
-3.9%
1Y
12.0%
HubSpot
Market Cap: US$23.1b
Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.
HUBS
US$429.90
7D
-6.9%
1Y
-12.2%
Sea
Market Cap: US$103.4b
Through its subsidiaries, operates as a consumer internet company in Southeast Asia, Latin America, the rest of Asia, and internationally.
SE
US$174.01
7D
16.9%
1Y
119.5%
Cellebrite DI
Market Cap: US$3.4b
Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
CLBT
US$15.29
7D
10.6%
1Y
2.2%
TuHURA Biosciences
Market Cap: US$128.5m
A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.
HURA
US$2.76
7D
13.6%
1Y
n/a
Zeta Global Holdings
Market Cap: US$4.4b
Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.
ZETA
US$17.81
7D
-9.0%
1Y
-26.8%
Market Cap: US$43.9b
Operates a digital community in the United States and internationally.
RDDT
US$243.47
7D
14.9%
1Y
338.3%
Anavex Life Sciences
Market Cap: US$907.0m
Operates as a biopharmaceutical company.
AVXL
US$10.11
7D
-9.9%
1Y
60.2%
Krystal Biotech
Market Cap: US$4.3b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$150.33
7D
10.5%
1Y
-22.5%
Commvault Systems
Market Cap: US$8.5b
Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.
CVLT
US$183.35
7D
-1.3%
1Y
23.8%
Evaxion
Market Cap: US$19.2m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$2.86
7D
-2.4%
1Y
-81.1%
MNTN
Market Cap: US$1.7b
Operates a technology platform that brings performance marketing to Connected TV.
MNTN
US$21.98
7D
-12.0%
1Y
n/a
Glimpse Group
Market Cap: US$28.0m
An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.
VRAR
US$1.33
7D
-4.3%
1Y
52.7%
Protalix BioTherapeutics
Market Cap: US$121.0m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.52
7D
0.7%
1Y
60.0%
Creative Medical Technology Holdings
Market Cap: US$8.3m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$3.07
7D
-17.7%
1Y
-11.1%
Trade Desk
Market Cap: US$26.6b
Operates as a technology company in the United States and internationally.
TTD
US$50.76
7D
-42.5%
1Y
-49.5%
Protagonist Therapeutics
Market Cap: US$3.5b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$54.99
7D
7.9%
1Y
35.5%
Arcturus Therapeutics Holdings
Market Cap: US$521.5m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$19.23
7D
60.5%
1Y
-5.1%
Prothena
Market Cap: US$433.3m
A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.
PRTA
US$8.06
7D
4.4%
1Y
-61.4%
Pure Storage
Market Cap: US$19.5b
Engages in the provision of data storage and management technologies, products, and services in the United States and internationally.
PSTG
US$57.85
7D
0.07%
1Y
-7.5%
Aprea Therapeutics
Market Cap: US$9.8m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.69
7D
2.4%
1Y
-50.4%
CarGurus
Market Cap: US$3.2b
Operates an online automotive platform for buying and selling vehicles in the United States and internationally.
CARG
US$31.75
7D
1.1%
1Y
12.5%
VTEX
Market Cap: US$764.2m
Provides software-as-a-service digital commerce platform for enterprise brands and retailers.
VTEX
US$3.96
7D
-33.1%
1Y
-46.2%
Exelixis
Market Cap: US$10.4b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$38.47
7D
2.9%
1Y
46.2%
Roku
Market Cap: US$13.0b
Operates a TV streaming platform in the United States and internationally.
ROKU
US$87.51
7D
5.3%
1Y
47.6%